financetom
Business
financetom
/
Business
/
CoreWeave Insider Sold Shares Worth $4,540,529, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CoreWeave Insider Sold Shares Worth $4,540,529, According to a Recent SEC Filing
Sep 20, 2025 11:00 PM

03:33 AM EDT, 09/19/2025 (MT Newswires) -- Nitin Agrawal, Chief Financial Officer, on September 16, 2025, sold 38,422 shares in CoreWeave ( CRWV ) for $4,540,529. Following the Form 4 filing with the SEC, Agrawal has control over a total of 319,445 Class A common shares of the company, with 145,588 shares held directly and 173,857 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1769628/000205803825000010/xslF345X05/form4-09192025_120926.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Array Digital Q3 Loss Narrows, Revenue Rises; New CEO Named
Array Digital Q3 Loss Narrows, Revenue Rises; New CEO Named
Nov 7, 2025
08:00 AM EST, 11/07/2025 (MT Newswires) -- Array Digital Infrastructure ( AD ) on Friday reported a Q3 loss of $0.44 per diluted share, narrower than a loss of $0.92 a year earlier. Two analysts polled by FactSet expected EPS of $0.30. Operating revenue for the quarter ended Sept. 30 was $47.1 million, up from $25.7 million a year earlier....
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
Pelthos Therapeutics Acquires Xepi® (ozenoxacin) Cream, 1% and Announces $18 Million Private Convertible Notes Financing
Nov 7, 2025
Acquisition adds complementary dermatology product to the Pelthos portfolio anchored by ZELSUVMI™Xepi is a novel FDA-approved topical treatment for impetigo that addresses a critical unmet need in antibiotic-resistant skin infections caused by staph and strep infections, most commonly affecting childrenImpetigo affects approximately 3 million people in the U.S. every year and is among the most common bacterial skin infections seen...
X-Rite to Acquire Select Assets of Rutherford Graphic Products (RGP), LLC (USA) in Strategic Expansion
X-Rite to Acquire Select Assets of Rutherford Graphic Products (RGP), LLC (USA) in Strategic Expansion
Nov 7, 2025
X-Rite has signed an agreement to acquire select assets of Rutherford Graphic Products, a provider of closed-loop press automation solutions for packaging converters. GRAND RAPIDS, Mich., Nov. 7, 2025 /PRNewswire/ -- X-Rite Incorporated, a global leader in color science and technology, is pleased to announce it has signed a definitive Assets Purchase Agreement to acquire certain software and firmware assets of Rutherford...
ACP Completes Growth Capital Investment in Advantage Investigations
ACP Completes Growth Capital Investment in Advantage Investigations
Nov 7, 2025
DALLAS & CLEVELAND--(BUSINESS WIRE)-- Align Capital Partners (“ACP”) recently completed the acquisition of Advantage Investigations (“Advantage” or the “Company”), a national insurance investigative services platform specializing in surveillance, research and related solutions, from MD Holdings. The new partnership will allow Advantage to further advance its growth strategy and technology roadmap, with CEO Shelly Kummings continuing in her role alongside ACP....
Copyright 2023-2026 - www.financetom.com All Rights Reserved